Advertisement

Management of Patient with Myasthenia Gravis

  • Sanchit Ahuja
  • Ashish K. KhannaEmail author
Chapter
  • 29 Downloads

Abstract

A 34-year-old woman with myasthenia gravis diagnosed 2 years ago is scheduled for an elective hysterectomy. She is currently on pyridostigmine 60 mg TID. Her vitals are normal for her age. Preoperative hematocrit is 30 g%. You are in pre-anesthesia clinic. Discuss the etiology, clinical features, and diagnostic tests for myasthenia gravis and its differential diagnosis? (Table 24.1)

References

  1. 1.
    Keesey JC. Clinical evaluation and management of myasthenia gravis. Muscle Nerve. 2004;29(4):484–505.PubMedCrossRefGoogle Scholar
  2. 2.
    Srivastava A, Kalita J, Misra UK. A comparative study of single fiber electromyography and repetitive nerve stimulation in consecutive patients with myasthenia gravis. Electromyogr Clin Neurophysiol. 2007;47(2):93–6.PubMedGoogle Scholar
  3. 3.
    Yuki N, Hartung HP. Guillain-Barre syndrome. N Engl J Med. 2012;366(24):2294–304.PubMedCrossRefGoogle Scholar
  4. 4.
    Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol. 1990;27(Suppl):S21–4.PubMedCrossRefGoogle Scholar
  5. 5.
    Krishnan C, Kaplin AI, Pardo CA, et al. Demyelinating disorders: update on transverse myelitis. Curr Neurol Neurosci Rep. 2006;6(3):236–43.PubMedCrossRefGoogle Scholar
  6. 6.
    Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology. 2002;59(4):499–505.Google Scholar
  7. 7.
    Beh SC, Greenberg BM, Frohman T, et al. Transverse myelitis. Neurol Clin. 2013;31(1):79–138.PubMedCrossRefGoogle Scholar
  8. 8.
    Rowland LP. What’s in a name? Amyotrophic lateral sclerosis, motor neuron disease, and allelic heterogeneity. Ann Neurol. 1998;43(6):691–4.PubMedCrossRefGoogle Scholar
  9. 9.
    Rowland LP. Progressive muscular atrophy and other lower motor neuron syndromes of adults. Muscle Nerve. 2010;41(2):161–5.PubMedCrossRefGoogle Scholar
  10. 10.
    Osserman KE, Kornfeld P, Cohen E, et al. Studies in myasthenia gravis: review of two hundred eighty-two cases at the Mount Sinai Hospital, New York City. AMA Arch Intern Med. 1958;102(1):72–81.PubMedCrossRefGoogle Scholar
  11. 11.
    Gilhus NE, Owe JF, Hoff JM, et al. Myasthenia gravis: a review of available treatment approaches. Autoimmune Dis. 2011;2011:847393.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Dretchen KL, Morgenroth VH 3rd, Standaert FG, et al. Azathioprine: effects on neuromuscular transmission. Anesthesiology. 1976;45(6):604–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Ahuja S, Cohen B, Hinkelbein J, et al. Practical anesthetic considerations in patients undergoing tracheobronchial surgeries: a clinical review of current literature. J Thorac Dis. 2016;8(11):3431–41.PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Wendell LC, Levine JM. Myasthenic crisis. Neurohospitalist. 2011;1(1):16–22.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Choi KH, Nam TS, Lee SH, et al. Preoperative pulmonary function is strongly related to myasthenic crisis after thymectomy. Neurol India. 2014;62(2):164–8.PubMedCrossRefGoogle Scholar
  16. 16.
  17. 17.
    Lin Y-P, Iqbal U, Nguyen P-A, et al. The Concomitant Association of Thyroid Disorders and Myasthenia Gravis. Transl Neurosci. 2017;8:27–30.PubMedPubMedCentralCrossRefGoogle Scholar
  18. 18.
    Grasso N, Celestre C, Borrata F, et al. An unexpected difficult intubation in a patient with myasthenia gravis undergoing video-assisted transcervical thymectomy. BMJ Case Rep. 2013;2013:bcr2013010135.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Leventhal SR, Orkin FK, Hirsh RA. Prediction of the need for postoperative mechanical ventilation in myasthenia gravis. Anesthesiology. 1980;53(1):26–30.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Grant RP, Jenkins LC. Prediction of the need for postoperative mechanical ventilation in myasthenia gravis: thymectomy compared to other surgical procedures. Can Anaesth Soc J. 1982;29(2):112–6.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Thomas CE, Mayer SA, Gungor Y, et al. Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology. 1997;48(5):1253–60.PubMedCrossRefGoogle Scholar
  22. 22.
    Chigurupati K, Gadhinglajkar S, Sreedhar R, et al. Criteria for postoperative mechanical ventilation after thymectomy in patients with myasthenia gravis: a retrospective analysis. J Cardiothorac Vasc Anesth. 2018;32(1):325–30.PubMedCrossRefGoogle Scholar
  23. 23.
    Usmani A, Kwan L, Wahib-Khalil D, et al. Excellent response to therapeutic plasma exchange in myasthenia gravis patients irrespective of antibody status. J Clin Apher. 2019;34(4):416–22.PubMedCrossRefGoogle Scholar
  24. 24.
    Baraka A, Taha S, Yazbeck V, et al. Vecuronium block in the myasthenic patient. Influence of anticholinesterase therapy. Anaesthesia. 1993;48(7):588–90.PubMedCrossRefGoogle Scholar
  25. 25.
    Romero A, Joshi GP. Neuromuscular disease and anesthesia. Muscle Nerve. 2013;48(3):451–60.PubMedCrossRefGoogle Scholar
  26. 26.
    Ferretti F, Crestani S, Rodriguez NJ, et al. [Can one use high thoracic epidural analgesia in postoperative intensive care of the myasthenia patient following trans-sternal thymectomy?]. Schweiz Med Wochenschr. 1987;117(12):438–41.Google Scholar
  27. 27.
    Mundada SD, Shah B, Atram S. Emergency cesarian section in a patient of myasthenia gravis: is neuraxial anesthesia safe? Saudi J Anaesth. 2012;6(4):430–1.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Abel M, Eisenkraft JB. Anesthetic implications of myasthenia gravis. Mt Sinai J Med. 2002;69(1–2):31–7.PubMedGoogle Scholar
  29. 29.
    Sinha A, Ahmad K, Harrop-Griffiths W. The use of a vertical infraclavicular brachial plexus block in a patient with myasthenia gravis: effects on lung function. Anaesthesia. 2001;56(2):165–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Hunter JM, McGrath CD. Monitoring of neuromuscular block. Contin Edu Anaesth Crit Care Pain. 2006;6(1):7–12.CrossRefGoogle Scholar
  31. 31.
    Takahashi K, Niiya T, Takada Y, et al. Severity of myasthenia gravis influences the relationship between train-of-four ratio and twitch tension and run-down of rat endplate potentials. Anesthesiology. 2016;124(2):369–77.PubMedCrossRefGoogle Scholar
  32. 32.
    Choi EM, Shim JK, Choi YS, et al. Persistent train-of-four fade in myasthenia gravis patients after sevoflurane anaesthesia. Br J Anaesth. 2008;100(5):724–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Pittinger CB, Eryasa Y, Adamson R. Antibiotic-induced paralysis. Anesth Analg. 1970;49(3):487–501.PubMedCrossRefGoogle Scholar
  34. 34.
    Hokkanen E. The aggravating effect of some antibiotics on the neuromuscular blockade in myasthenia gravis. Acta Neurol Scand. 1964;40(4):346–52.PubMedCrossRefGoogle Scholar
  35. 35.
    Cadisch R, Streit E, Hartmann K. [Exacerbation of pseudoparalytic myasthenia gravis following azithromycin (Zithromax)]. Schweiz Med Wochenschr. 1996;126(8):308–10.Google Scholar
  36. 36.
    Gunduz A, Turedi S, Kalkan A, et al. Levofloxacin induced myasthenia crisis. Emerg Med J. 2006;23(8):662.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Albrecht RF 2nd, Lanier WL. Potentiation of succinylcholine-induced phase II block by vancomycin. Anesth Analg. 1993;77(6):1300–2.PubMedCrossRefGoogle Scholar
  38. 38.
    So EL, Penry JK. Adverse effects of phenytoin on peripheral nerves and neuromuscular junction: a review. Epilepsia. 1981;22(4):467–73.PubMedCrossRefGoogle Scholar
  39. 39.
    Bikhazi GB, Leung I, Flores C, et al. Potentiation of neuromuscular blocking agents by calcium channel blockers in rats. Anesth Analg. 1988;67(1):1–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Rath J, Mauritz M, Zulehner G, et al. Iodinated contrast agents in patients with myasthenia gravis: a retrospective cohort study. J Neurol. 2017;264(6):1209–17.PubMedPubMedCentralCrossRefGoogle Scholar
  41. 41.
    Matsuo S, Rao DB, Chaudry I, et al. Interaction of muscle relaxants and local anesthetics at the neuromuscular junction. Anesth Analg. 1978;57(5):580–7.PubMedCrossRefGoogle Scholar
  42. 42.
    Nitahara K, Sugi Y, Higa K, et al. Neuromuscular effects of sevoflurane in myasthenia gravis patients. Br J Anaesth. 2007;98(3):337–41.PubMedCrossRefGoogle Scholar
  43. 43.
    Itoh H, Shibata K, Nitta S. Sensitivity to vecuronium in seropositive and seronegative patients with myasthenia gravis. Anesth Analg. 2002;95(1):109–13, table of contents.PubMedCrossRefGoogle Scholar
  44. 44.
    Itoh H, Shibata K, Nitta S. Difference in sensitivity to vecuronium between patients with ocular and generalized myasthenia gravis. Br J Anaesth. 2001;87(6):885–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Mann R, Blobner M, Jelen-Esselborn S, et al. Preanesthetic train-of-four fade predicts the Atracurium requirement of myasthenia gravis patients. Anesthesiology. 2000;93(2):346–50.PubMedCrossRefGoogle Scholar
  46. 46.
    Sungur Ulke Z, Yavru A, Camci E, et al. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy. Acta Anaesthesiol Scand. 2013;57(6):745–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Iwasaki H, Takahoko K, Otomo S, et al. Monitoring of neuromuscular blockade in one muscle group alone may not reflect recovery of total muscle function in patients with ocular myasthenia gravis. Can J Anaesth. 2013;60(12):1222–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Seneviratne J, Mandrekar J, Wijdicks EFM, et al. Predictors of extubation failure in Myasthenic crisis. Arch Neurol. 2008;65(7):929–33.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  1. 1.Department of AnesthesiologyPain management and Perioperative Medicine, Henry Ford Health SystemsDetroitUSA
  2. 2.Department of Anesthesiology, Section on Critical Care MedicineWake Forest School of MedicineWinston-SalemUSA

Personalised recommendations